Addressing End-of-Life Care in Anticipation of the 2040 Issue
First written in FY2023. 4 of 9 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「Going forward, in an environment where the arrival of the “2040 problem,” when the elderly population is expected to peak, is anticipated, the Group will conduct its business as a company that addresses the challenges of a super-aged society by further increasing the number of users of home-visit massage services.」
The means of addressing the 2040 problem and end-of-life care changed from expanding hospice facilities to addressing these issues after the hospice transfer by increasing the number of home-visit massage users. - FY2026-H1RestatedAnnual report
「Going forward, in the expected environment in which the “2040 problem,” when the elderly population is expected to peak, will emerge, the Group will operate as a company that addresses issues in the super-aging society by further increasing service users through the opening of new hospice facilities and nursing small-scale multifunctional home care facilities.」
In anticipation of the 2040 problem, the Company reiterates its policy of addressing these issues through the opening of new hospice and small-scale multifunctional in-home care facilities. - FY2025ReframedAnnual report
「The Group has operated its business based on a core strategy of growth centered on the medical-care residential facilities (hospice) business included in its facility-based care services business. However, the business environment remains challenging, with delays in acquiring users and recruiting personnel.」
The Company had expanded the hospice business to address end-of-life care in anticipation of the 2040 problem, but its policy changed to transferring the entire hospice business against a backdrop of delays in acquiring users and recruiting personnel. - FY2025-H1AdvancedAnnual report
「In the expected environment in which the “2040 problem,” when the elderly population is expected to peak, will emerge, the Group will operate as a company that addresses issues in the super-aging society by further increasing service users through the opening of new hospice facilities and nursing small-scale multifunctional home care facilities.」
As a specific measure to address end-of-life care in anticipation of the 2040 problem, the Company expanded the number of newly opened hospice facilities from 3 in the previous fiscal year to 7. - FY2024RestatedAnnual report
「In the expected environment in which the “2025 problem,” under which 1 in 3 people in Japan will be aged 65 or older and 1 in 5 will be aged 75 or older, and the “2040 problem,” when the elderly population is expected to peak, will emerge, the company launched its new hospice business in March 2023 to enable the Group to operate as a company that addresses issues in the super-aging society by further increasing service users through stronger corporate sales to nursing care facilities and other institutions.」
In anticipation of the 2040 problem, the Company reiterates its direction of addressing issues in the home-care field, including end-of-life care, through the hospice business. - FY2024-Q3RestatedAnnual report
「In the expected environment in which the “2025 problem,” under which 1 in 3 people in Japan will be aged 65 or older and 1 in 5 will be aged 75 or older, and the “2040 problem,” when the elderly population is expected to peak, will emerge, the company launched its new hospice business in March 2023 to enable the Group to operate as a company that addresses issues in the super-aging society by further increasing service users through stronger corporate sales to nursing care facilities and other institutions.」
In anticipation of the 2040 problem, the Company reiterates its direction of addressing issues in the home-care field, including end-of-life care, through the hospice business. - FY2024-Q2RestatedAnnual report
「In the expected environment in which the “2025 problem,” under which 1 in 3 people in Japan will be aged 65 or older and 1 in 5 will be aged 75 or older, and the “2040 problem,” when the elderly population is expected to peak, will emerge, the company launched its new hospice business in March 2023 to enable the Group to operate as a company that addresses issues in the super-aging society by further increasing service users through stronger corporate sales to nursing care facilities and other institutions.」
In anticipation of the 2040 problem, the Company reiterates its policy of addressing issues in the home-care field, including end-of-life care, through the hospice business. - FY2024-Q1AdvancedAnnual report
「In the expected environment in which the “2025 problem,” under which 1 in 3 people in Japan will be aged 65 or older and 1 in 5 will be aged 75 or older, and the “2040 problem,” when the elderly population is expected to peak, will emerge, the company launched its new hospice business in March 2023 to enable the Group to operate as a company that addresses issues in the super-aging society by further increasing service users through stronger corporate sales to nursing care facilities and other institutions.」
The disclosure states that the Company began the hospice business in March 2023 as a specific measure to address end-of-life care in anticipation of the 2040 problem. - FY2023First statedAnnual report
「In anticipation of the “2040 problem,” when Japan's elderly population is expected to peak, demand for end-of-life care is expected to increase. Fureasu aims to become “a company providing comprehensive support in the home-care field, rather than a home-visit massage services company.” To provide services for a wide range of conditions, the Company decided to enter the hospice business as a new business, offering palliative care focused on pain and emotional support so that people can spend the final stage of their lives in a way true to themselves.」
Separately from the 2025 problem, the Company has for the first time explicitly stated its policy of becoming a company that provides comprehensive support in the home-care field, in anticipation of the peak in Japan's elderly population in 2040 and growing demand for end-of-life care.